Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-12

Clinical Trial Update: ReSure Sealant Pivotal Study [Phase 3]

View source ↗

Summary

The pivotal Phase 3 trial evaluating ReSure Sealant for preventing cataract surgery incision leaks has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ReSure Sealant (polyethylene glycol hydrogel sealant)

Snippet

Sponsor: Ocular Therapeutix, Inc. | Conditions: Cataract Surgery Incision Leak | Phase 3 | Status: COMPLETED